| General Information of Drug Metabolite (DM) (ID: DM000243) |
| DM Name |
Lesinurad metabolite M3b
|
|
|
|
|
|
|
|
| Full List of Drug-Metabolizing Enzyme (DME) Related to This DM |
| DME(s) Producing This DM through Metabolism |
| DME Name |
DME ID |
Reactant |
Reaction |
Related Drug |
REF |
|
Cytochrome P450 2C9 (CYP2C9)
|
DME0019
|
| Oxidation - Hydroxylation |
Lesinurad
|
[1] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Full List of Drug(s) That Produce This DM By Metabolism |
| Lesinurad |
DR0926
|
Approved |
Uncontrolled gout |
|
|
| References |
| 1 |
Characterization of Stereoselective Metabolism, Inhibitory Effect on Uric Acid Uptake Transporters, and Pharmacokinetics of Lesinurad Atropisomers Drug Metab Dispos. 2019 Feb;47(2):104-113. doi: 10.1124/dmd.118.080549.
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.
